Henry M. Jackson Foundation for the Advancement of Military Medicine

Advancing Military Medicine

Search Results - ly6k

1 Results Sort By:
Small Molecule Targeted Therapeutics for Breast Cancer - (HJF 533-19)
A technology related to using novel small molecule therapeutics for breast cancer treatment is available for licensing from HJF. These small molecules specifically inhibit LY6K, a cancer-testis oncoprotein, in cancer cells, thus providing a novel targeted therapy for breast, colorectal, and other cancers. Applications and Advantages Targeted therapeutics...
Published: 10/17/2024   |   Updated: 1/23/2023   |   Inventor(s): Geeta Upadhyay
Keywords(s): Breast Cancer, Cancer, Colorectal Cancer, LY6K, Oncogene, Small Molecule, Therapeutics
Category(s): Therapeutic